help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on May 15, 2007
Journal of Clinical Endocrinology & Metabolism, doi:10.1210/jc.2007-0505
A more recent version of this article appeared on August 1, 2007
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
92/8/3305    most recent
Author Manuscript (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Barbaro, M.
Right arrow Articles by Wedell, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Barbaro, M.
Right arrow Articles by Wedell, A.
Related Collections
Right arrow Pediatric Endocrinology

Submitted on March 5, 2007
Accepted on May 7, 2007

Isolated 46,XY gonadal dysgenesis in two sisters caused by a Xp21.2 interstitial duplication containing the DAX1 gene

Michela Barbaro*, Mikael Oscarson, Jacqueline Schoumans, Johan Staaf, Sten A Ivarsson, and Anna Wedell

Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden; Department of Oncology, Lund University, Lund, Sweden; Department of Paediatrics, Malmö University Hospital, Lund University, Malmö, Sweden

* To whom correspondence should be addressed. E-mail: Michela.barbaro{at}ki.se.

Context: Testis development is a tightly regulated process that requires an efficient and coordinated spatio-temporal action of many factors and it has been shown that several genes involved in gonadal development exert a dosage effect. Chromosomal imbalances have been reported in several patients presenting with gonadal dysgenesis (gonadal dysgenesis) as part of severe dysmorphic phenotypes.

Results: We screened for submicroscopic DNA copy number variations in two sisters with an apparent normal 46,XY karyotype and female external genitalia due to gonadal dysgenesis and in which mutations in known candidate genes had been excluded. By high resolution tiling BAC array comparative genome hybridization, a submicroscopic duplication at Xp21.2 containing DAX1 (NR0B1) was identified. Using FISH, multiple ligation probe amplification and PCR the rearrangement was further characterized. This revealed a 637 kb tandem duplication that in addition to DAX1 includes the four MAGEB genes, the hypothetical gene CXorf21, GK and part of the MAP3K7IP3 gene. Sequencing and analysis of the breakpoint boundaries and duplication junction suggest that the duplication originated through a coupled homologous and nonhomologous recombination process.

Conclusion: This represents the first duplication on Xp21.2 identified in patients with isolated gonadal dysgenesis, as all previously described XY subjects with Xp21 duplications presented with gonadal dysgenesis as part of a more complex phenotype including mental retardation and/or malformations. Our data thus support DAX1 as a dosage sensitive gene responsible for gonadal dysgenesis, and highlight the importance of considering DAX1 locus duplications in the evaluation of all cases of 46,XY gonadal dysgenesis.


Key words: NR0B1 • gonadal dysgenesis • disorders of sex development (DSD) • sex reversal • array-CGH • multiple ligation probe amplification (MLPA)




This article has been cited by other articles:


Home page
Endocr Relat CancerHome page
J.-J. Lee, A. Y M Au, T. Foukakis, M. Barbaro, N. Kiss, R. Clifton-Bligh, J. Staaf, A. Borg, L. Delbridge, B. G Robinson, et al.
Array-CGH identifies cyclin D1 and UBCH10 amplicons in anaplastic thyroid carcinoma
Endocr. Relat. Cancer, September 1, 2008; 15(3): 801 - 815.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2007 by The Endocrine Society